Regeneron Pharmaceuticals Inc (REGN) — Quality & forensics

As of 2026-08-06 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

60 /100 composite · 7 modules · general weight set

Valuation 72
Quality 69
Growth 40
Balance sheet 76
Cash quality 33
Capital allocation 77
Momentum 51

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

7.39 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

5/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.58 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the REGN chart & overview

FAQ · from the current data · as of 2026-08-06

Quick answers

What is Regeneron Pharmaceuticals Inc's Closelook quality reading?

The composite reads 60/100 across 7 modules, as of 2026-08-06: valuation 72, quality 69, growth 40, balance sheet 76, cash quality 33, capital allocation 77, momentum 51. Closelook scores are research diary readings, not ratings or investment advice.

What is Regeneron Pharmaceuticals Inc's Altman Z-Score?

7.39, which sits in the safe zone (above 2.99) as of 2026-08-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Regeneron Pharmaceuticals Inc's Piotroski F-Score?

5 of 9, as of 2026-08-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Regeneron Pharmaceuticals Inc's Beneish M-Score indicate?

-2.58 — below the −1.78 manipulation-risk threshold, as of 2026-08-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.